PURPOSE: The purpose of the present study was to investigate the role of nuclear factor of activated T cells (NFAT), a transcription factor downstream of VEGF, in angiogenic cell behaviors of human retinal microvascular endothelial cells (HRMEC), and to assess the efficacy of NFAT signaling inhibitors in a rat model of oxygen-induced retinopathy (OIR). METHODS: Human retinal microvascular endothelial cells were treated with VEGF in the presence or absence of the NFAT inhibitor of NFAT-calcineurin association-6 (INCA-6), and NFAT translocation was evaluated using immunocytochemistry (ICC). Human retinal microvascular endothelial cells were treated with increasing doses of INCA-6, and cell proliferation and tube formation were assessed. Rats subjected to OIR were administered increasing doses of INCA-6 or the CN inhibitor FK-506, and the retinal neovascular area was measured. RESULTS: Nuclear factor of activated T-cells c1 was translocated to the nucleus of HRMEC treated with VEGF, and INCA-6 treatment blocked translocation. Inhibitor of NFAT-calcineurin association-6inhibited HRMEC proliferation and tube formation in a dose-dependent manner. Both INCA-6 and FK-506 treatment significantly reduced pathologic neovascularization in OIR. CONCLUSIONS: This investigation has demonstrated that in HRMEC, NFATc1 is activated downstream of VEGF signaling and NFAT signaling plays a key role in angiogenic cell behaviors. In addition, NFAT inhibition is shown to be highly efficacious in an OIR model. These findings indicate that the NFAT signaling pathway may serve as a suitable therapeutic target for the treatment of neovascular eye disease.
PURPOSE: The purpose of the present study was to investigate the role of nuclear factor of activated T cells (NFAT), a transcription factor downstream of VEGF, in angiogenic cell behaviors of human retinal microvascular endothelial cells (HRMEC), and to assess the efficacy of NFAT signaling inhibitors in a rat model of oxygen-induced retinopathy (OIR). METHODS:Human retinal microvascular endothelial cells were treated with VEGF in the presence or absence of the NFAT inhibitor of NFAT-calcineurin association-6 (INCA-6), and NFAT translocation was evaluated using immunocytochemistry (ICC). Human retinal microvascular endothelial cells were treated with increasing doses of INCA-6, and cell proliferation and tube formation were assessed. Rats subjected to OIR were administered increasing doses of INCA-6 or the CN inhibitor FK-506, and the retinal neovascular area was measured. RESULTS: Nuclear factor of activated T-cells c1 was translocated to the nucleus of HRMEC treated with VEGF, and INCA-6 treatment blocked translocation. Inhibitor of NFAT-calcineurin association-6inhibited HRMEC proliferation and tube formation in a dose-dependent manner. Both INCA-6 and FK-506 treatment significantly reduced pathologic neovascularization in OIR. CONCLUSIONS: This investigation has demonstrated that in HRMEC, NFATc1 is activated downstream of VEGF signaling and NFAT signaling plays a key role in angiogenic cell behaviors. In addition, NFAT inhibition is shown to be highly efficacious in an OIR model. These findings indicate that the NFAT signaling pathway may serve as a suitable therapeutic target for the treatment of neovascular eye disease.
Authors: Michael H A Roehrl; Sunghyun Kang; José Aramburu; Gerhard Wagner; Anjana Rao; Patrick G Hogan Journal: Proc Natl Acad Sci U S A Date: 2004-05-06 Impact factor: 11.205
Authors: K T Shaw; A M Ho; A Raghavan; J Kim; J Jain; J Park; S Sharma; A Rao; P G Hogan Journal: Proc Natl Acad Sci U S A Date: 1995-11-21 Impact factor: 11.205
Authors: Natalie K Thulin; R Camille Brewer; Robert Sherwood; Stylianos Bournazos; Karlie G Edwards; Nitya S Ramadoss; Jeffery K Taubenberger; Matthew Memoli; Andrew J Gentles; Prasanna Jagannathan; Sheng Zhang; Daniel H Libraty; Taia T Wang Journal: Cell Rep Date: 2020-05-12 Impact factor: 9.423
Authors: Meredith J Giblin; Taylor E Smith; Garrett Winkler; Hannah A Pendergrass; Minjae J Kim; Megan E Capozzi; Rong Yang; Gary W McCollum; John S Penn Journal: Biochim Biophys Acta Mol Basis Dis Date: 2021-07-31 Impact factor: 5.187
Authors: John Paul SanGiovanni; Jing Chen; Ankur S Gupta; Lois E H Smith; Przemyslaw Sapieha; Phil H Lee Journal: PLoS One Date: 2015-05-07 Impact factor: 3.240
Authors: Anna V Zetterqvist; Fabiana Blanco; Jenny Öhman; Olga Kotova; Lisa M Berglund; Sergio de Frutos Garcia; Raed Al-Naemi; Maria Wigren; Paul G McGuire; Laura V Gonzalez Bosc; Maria F Gomez Journal: J Diabetes Res Date: 2015-03-31 Impact factor: 4.011